Invitrogen adopts BioMicro’s MAUI Hybridization System.
Salt Lake City, UT – August 22, 2006 - BioMicro® Systems, Inc. announced today that Invitrogen Corporation has adopted the company’s MAUI® (MicroArray User Interface) Hybridization System as its hybridization system of choice for their microarray experiments. Specifically, the MAUI System will be used with Invitrogen’s new NCode miRNA profiling platform.
BioMicro’s successful hybridization platform, the MAUI System, will be used with Invitrogen’s NCode arrays to enhance miRNA research. Our aim is to provide a complete solution to ensure successful miRNA research for drug discovery and therapeutic applications.
“Preliminary data shows that using the MAUI System with the NCode arrays easily results in an impressive 10 fold gain in sensitivity compared to manual hybridization,” said Invitrogen’s Senior Scientist and NCode Product Manager, Christopher Adams. He adds, “We have already implemented the MAUI System into our NCode miRNA Analysis Service because we have seen such solid results.”
BioMicro System’s Business Development Manager, Kayla Holmes said, “BioMicro is pleased to be working with Invitrogen. By working with Invitrogen, the expertise and capabilities of both companies are united to provide an exponentially better solution for miRNA research. We believe this alliance further validates the MAUI System as a leader in the field of microarray hybridization.”
About Invitrogen
Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology - placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California and conducts business in more than 70 countries around the world. The company globally employs approximately 4,800 scientists and other professionals and had revenues of more than $1 billion in 2004. For more information, visit www.invitrogen.com.
About BioMicro Systems, Inc.:
BioMicro Systems, Inc., founded in 2000 and based in Salt Lake City, Utah, is a private company focused on the development and commercialization of biological research products based on its proprietary microfluid and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. To date, over 300 MAUI Systems have been sold worldwide. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. More company information can be found at www.biomicro.com.
For MAUI System specifications, product demos, and sales information in the United States and other countries, please contact:
BioMicro Systems, Inc.
Phone: 801-303-1470
E-mail: info@biomicro.com
BioMicro Systems, Inc.
1290 West 2320 South • Suite D • Salt Lake City, UT
• 84119-1476 • USA
801.303.1470 • FAX 801.303.1471
